Senseonics Holdings, Inc. (SENS): Price and Financial Metrics
SENS Price/Volume Stats
| Current price | $0.42 | 52-week high | $1.05 |
| Prev. close | $0.40 | 52-week low | $0.40 |
| Day low | $0.40 | Volume | 2,226,700 |
| Day high | $0.43 | Avg. volume | 2,510,195 |
| 50-day MA | $0.57 | Dividend yield | N/A |
| 200-day MA | $0.60 | Market Cap | 220.82M |
SENS Stock Price Chart Interactive Chart >
Senseonics Holdings, Inc. (SENS) Company Bio
Senseonics Holdings, Inc. focuses on the design, development, and commercialization of glucose monitoring systems for people with diabetes. The company was founded in 1996 and is based in Germantown, Maryland.
Latest SENS News From Around the Web
Below are the latest news stories about SENSEONICS HOLDINGS INC that investors may wish to consider to help them evaluate SENS as an investment opportunity.
Senseonics Holdings, Inc. (AMEX:SENS) Q3 2023 Earnings Call TranscriptSenseonics Holdings, Inc. (AMEX:SENS) Q3 2023 Earnings Call Transcript November 9, 2023 Senseonics Holdings, Inc. reports earnings inline with expectations. Reported EPS is $-0.04 EPS, expectations were $-0.04. Operator: Good day and welcome to the Senseonics Third Quarter 2023 Earnings Conference Call. All participants will be in listen-only mode. [Operator Instructions] Please note today’s event […] |
Q3 2023 Senseonics Holdings Inc Earnings CallQ3 2023 Senseonics Holdings Inc Earnings Call |
Senseonics Holdings, Inc. Reports Third Quarter 2023 Financial ResultsGERMANTOWN, Md., November 09, 2023--Senseonics Holdings, Inc. (NYSE American: SENS), a medical technology company focused on the development and manufacturing of long-term, implantable continuous glucose monitoring (CGM) systems for people with diabetes, today reported financial results for the quarter ended September 30, 2023. |
Senseonics Holdings, Inc. to Participate in the Stifel 2023 Healthcare ConferenceGERMANTOWN, Md., November 09, 2023--Senseonics Holdings, Inc. (NYSE American: SENS), a medical technology company focused on the development and manufacturing of long-term, implantable continuous glucose monitoring (CGM) systems for people with diabetes, today announced plans to participate in the upcoming Stifel 2023 Healthcare Conference, taking place in New York, NY. |
Phreesia (PHR) Surges 10.3%: Is This an Indication of Further Gains?Phreesia (PHR) saw its shares surge in the last session with trading volume being higher than average. The latest trend in earnings estimate revisions may not translate into further price increase in the near term. |
SENS Price Returns
| 1-mo | -26.39% |
| 3-mo | -19.39% |
| 6-mo | -17.65% |
| 1-year | -33.55% |
| 3-year | -76.27% |
| 5-year | -78.46% |
| YTD | -26.33% |
| 2023 | -44.65% |
| 2022 | -61.42% |
| 2021 | 206.26% |
| 2020 | -4.83% |
| 2019 | -64.63% |
Continue Researching SENS
Want to do more research on Senseonics Holdings Inc's stock and its price? Try the links below:Senseonics Holdings Inc (SENS) Stock Price | Nasdaq
Senseonics Holdings Inc (SENS) Stock Quote, History and News - Yahoo Finance
Senseonics Holdings Inc (SENS) Stock Price and Basic Information | MarketWatch
Loading social stream, please wait...